Haleon plc (HLN) - Total Assets

Latest as of December 2025: $32.57 Billion USD

Based on the latest financial reports, Haleon plc (HLN) holds total assets worth $32.57 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Haleon plc to assess how comfortably operating cash covers total debt obligations.

Haleon plc - Total Assets Trend (2019–2025)

This chart illustrates how Haleon plc's total assets have evolved over time, based on quarterly financial data. See what is Haleon plc's book value for net asset value and shareholders' equity analysis.

Haleon plc - Asset Composition Analysis

Current Asset Composition (December 2025)

Haleon plc's total assets of $32.57 Billion consist of 13.9% current assets and 86.1% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 4.1%
Accounts Receivable $2.12 Billion 6.5%
Inventory $1.02 Billion 3.1%
Property, Plant & Equipment $2.00 Billion 6.1%
Intangible Assets $17.49 Billion 53.7%
Goodwill $25.57 Billion 78.5%

Asset Composition Trend (2019–2025)

This chart illustrates how Haleon plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see HLN market cap.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Haleon plc's current assets represent 13.9% of total assets in 2025, a decrease from 16.3% in 2019.
  • Cash Position: Cash and equivalents constituted 4.1% of total assets in 2025, up from 1.0% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 131.0% of total assets, an increase from 77.0% in 2019.
  • Asset Diversification: The largest asset category is goodwill at 78.5% of total assets.

Haleon plc Competitors by Total Assets

Key competitors of Haleon plc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Sweden Skr81.26 Billion
Alkem Laboratories Limited
NSE:ALKEM
India Rs202.87 Billion
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
China CN¥12.75 Billion
Alkermes plc
F:8AK
Germany €4.26 Billion
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
China CN¥35.27 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
China CN¥6.49 Billion
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
China CN¥1.41 Billion

Haleon plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.92 0.98 1.24
Quick Ratio 0.71 0.78 1.01
Cash Ratio 0.27 0.39 0.00
Working Capital $-382.33 Million $-94.00 Million $1.01 Billion

Haleon plc - Advanced Valuation Insights

This section examines the relationship between Haleon plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.83
Latest Market Cap to Assets Ratio 1.24
Asset Growth Rate (YoY) -5.1%
Total Assets $32.57 Billion
Market Capitalization $40.34 Billion USD

Valuation Analysis

Above Book Valuation: The market values Haleon plc's assets above their book value (1.24x), reflecting positive investor sentiment about the company's future prospects.

Significant Asset Reduction: Haleon plc's assets decreased by 5.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Haleon plc (2019–2025)

The table below shows the annual total assets of Haleon plc from 2019 to 2025.

Year Total Assets Change
2025-12-31 $32.57 Billion -5.08%
2024-12-31 $34.31 Billion +0.76%
2023-12-31 $34.05 Billion -2.18%
2022-12-31 $34.81 Billion +1.06%
2021-12-31 $34.45 Billion +0.94%
2020-12-31 $34.13 Billion -4.43%
2019-12-31 $35.71 Billion --

About Haleon plc

NYSE:HLN USA Drug Manufacturers - Specialty & Generic
Market Cap
$44.01 Billion
Market Cap Rank
#672 Global
#320 in USA
Share Price
$9.95
Change (1 day)
+1.74%
52-Week Range
$8.70 - $11.27
All Time High
$11.41
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; an… Read more